These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7000124)

  • 1. Experimental chemotherapy studies: intercomparison of assays.
    Twentyman PR
    Br J Cancer Suppl; 1980 Apr; 4():279-87. PubMed ID: 7000124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR
    Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity to tumour cells of diethylaminoreserpine.
    Lehnert S
    Br J Cancer Suppl; 1980 Apr; 4():222-5. PubMed ID: 6932928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival.
    Begg AC; Fu KK; Kane LJ; Phillips TL
    Cancer Res; 1980 Jan; 40(1):145-54. PubMed ID: 7349894
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival.
    Twentyman PR
    Br J Cancer; 1980 Aug; 42(2):297-304. PubMed ID: 7426337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B; Sibamoto J; Abe M
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of repair of potentially lethal damage in assays of cytotoxic agents.
    Richie JP; Weichselbaum RR; Little JB
    Surgery; 1982 Aug; 92(2):380-4. PubMed ID: 7101131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.
    Krause M; Zips D; Thames HD; Kummermehr J; Baumann M
    Radiother Oncol; 2006 Aug; 80(2):112-22. PubMed ID: 16916560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice.
    Jagetia GC; Baliga MS; Venkatesh P; Ulloor JN; Mantena SK; Genebriera J; Mathuram V
    J Pharm Pharmacol; 2005 Sep; 57(9):1213-9. PubMed ID: 16105243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between surviving fractions using the colony methods, the LD50, and the growth delay after irradiation of human melanoma cells grown as multicellular spheroids.
    Pourreau-Schneider N; Malaise EP
    Radiat Res; 1981 Feb; 85(2):321-32. PubMed ID: 7465784
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines.
    Leung PY; Miyashita K; Young M; Tsao CS
    Anticancer Res; 1993; 13(2):475-80. PubMed ID: 8517665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour growth and cancer therapy.
    Denekamp J
    Br J Hosp Med; 1980 Jun; 23(6):566, 568, 570-1 passim. PubMed ID: 7437594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors.
    Braunschweiger PG; Basrur VS; Santos O; Markoe AM; Houdek PV; Schwade JG
    Cancer Res; 1993 Mar; 53(5):1091-7. PubMed ID: 8439953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.
    Miller RA; Woodburn KW; Fan Q; Lee I; Miles D; Duran G; Sikic B; Magda D
    Clin Cancer Res; 2001 Oct; 7(10):3215-21. PubMed ID: 11595717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
    Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
    Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of tumor regrowth to tumor cell survival, tumor cure rates and host survival in a solid tumor model following combined chemotherapy and radiotherapy.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):97-105. PubMed ID: 8054518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.